永安药业(002365.SZ)：拟对全资子公司凌安科技进行吸收合并

Group 1 - The core viewpoint of the article is that Yong'an Pharmaceutical (002365.SZ) is planning to absorb and merge its wholly-owned subsidiary Hubei Ling'an Technology Co., Ltd. to optimize management structure and improve operational efficiency [1] - The merger aims to reduce management costs and integrate quality resources within the company [1] - Upon completion of the merger, Ling'an Technology will be dissolved, and all its assets, debts, business operations, personnel, and other rights and obligations will be legally inherited by the company [1]